Australia's largest stock trading and investment forum Australia's #1 stock forum

WFL

Click for more information

0.00%

0.3¢ wellfully limited

28 April 2014, page-37

First 37 Last

Share
Profile

Follow
cmk1969

3,636 Posts.

1021

30/04/15

11:14

Post #: 15187592
Share

Originally posted by gbr ↑

Hi Jasetheace40,

To answer this question you may need to go back to “the Future” to where it all began, which in this case is 2004. But first let me ask Jeff a question –

“Hey Jeff can you tell us what the results were for the P&G trials?”

“We have completed the first of 3 clinical studies and in fact of those important with P&G before you ask no I can’t tell you what the outcomes of those are because the clinical results are not OBJ’s property” ~ Jeff Edwards, 2013 AGM

As our partnership with P&G has been announced any developments in this area apart from the results should be notified to shareholders, but if a trial is conducted with a “potential partner” would this be notified or remain confidential as no agreement is in place?

Below are some announcements that may be relevant to the subject raised by yourself, regarding Pfizer

The above announcement [08.06.2005] led to a further announcement on Friday 11th, November, 2005 where it was disclosed that the Vaccine that was used was Glanvac, which is a Pfizer vaccine.

You would have to agree that these results would have been relayed to Pfizer or that Pfizer may have been involved in the trial…..

In 2007 OBJ created OBJ Transdermal Vaccines [OBJTV] and hired staff, these staff were located at University of QLD

If we now move to 2010 we will find that OBJTV has disappeared off the radar – why…..

Any questions that are raised regarding OBJ’s technology in the Pharmaceutical area is met with this response –

Where still are keeping relatively away from long term deeply expensive pharmaceuticals activities ~ Jeff Edwards, 2013 AGM

But wait….what was that – “OBJ is currently engaged in pharmaceutical drug patch evaluations with major international pharmaceutical companies”, this couldn’t be Pfizer by any chance….

I could go on but will finish with this

From the reply that cmk1969 received on the 19.10.2013 no mention is made of the results from the University QLD that were conducted in 2012…..

Although the above is pure “speculation” why would OBJTV disappear off the radar after encouraging results, which of our Partners has a large Vaccine portfolio, that would benefit from OBJ’s technology……and which partner recently gained additional Vaccine products

Perhaps we may have gained a new “potential” partner

Expand

Nice one GBR.......and now Zoetis is now over US$45 per share, with a PE of nearly 39

http://quotes.wsj.com/ZTS

Do you ever get the feeling with so many collaborations and some spanning more than a decade already, that perhaps using the term 'exciting' for 2015 may eventually seem like an understatement? Imo it is no coincidence that Pfizer has now OFFICIALLY entered the OBJ arena after very important global validation from the likes of P&G........these are indeed 'exciting' times; and who would know better than those close to the pulse - OBJ Management .

OBJ Price at posting: 6.9¢ Sentiment: Hold Disclosure: Held
25 Upvote

0 Great analysis

Reply

Top Stories

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

First 37 Last

Add WFL (ASX) to my watchlist